Literature DB >> 3732083

Serological identification of Branhamella catarrhalis. Serological evidence for infection.

I Eliasson.   

Abstract

A protein antigen--P-antigen--characteristic of Branhamella catarrhalis has been described. Precipitating antibodies against this antigen occur in a majority of healthy human sera; serological evidence for a pathogenic role of B. catarrhalis is accumulating. The occurrence of complement-fixing antibodies has been demonstrated during bronchopulmonary infection with B. catarrhalis and in maxillary sinusitis. Increases in antibody titres assessed by an enzyme-linked immunosorbent assay (ELISA) technique have been reported in children with acute otitis media. An ELISA, using purified P-antigen, for the evaluation of IgG, IgM and IgA antibodies against B. catarrhalis is being developed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732083     DOI: 10.2165/00003495-198600313-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  13 in total

1.  Immunological relationships of some non-pathogenic Neisseria.

Authors:  R R Russell; K G Johnson; I J McDonald
Journal:  Can J Microbiol       Date:  1978-02       Impact factor: 2.419

2.  Transfer of beta-lactamase production in Branhamella catarrhalis.

Authors:  C Kamme; M Vang; S Ståhl
Journal:  Scand J Infect Dis       Date:  1983

3.  Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis.

Authors:  K G Johnson; I J McDonald; M B Perry
Journal:  Can J Microbiol       Date:  1976-04       Impact factor: 2.419

4.  Comparison of the cell envelope proteins of Micrococcus cryophilus with those of Neisseria dnd Branhamella species.

Authors:  R R Russell; I J McDonald
Journal:  Can J Microbiol       Date:  1976-02       Impact factor: 2.419

5.  Use of the API NeIdent system for identification of pathogenic Neisseria spp. and Branhamella catarrhalis.

Authors:  W M Janda; J A Morello; M Bohnhoff
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

6.  Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production.

Authors:  C Kamme; M Wang; S Ståhl
Journal:  Scand J Infect Dis       Date:  1984

7.  Diagnostic value of interactions between members of the family Neisseriaceae and lectins.

Authors:  R J Doyle; F Nedjat-Haiem; K F Keller; C E Frasch
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

8.  Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis.

Authors:  M Leinonen; J Luotonen; E Herva; K Valkonen; P H Mäkelä
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

9.  A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus.

Authors:  I Eliasson
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-10

10.  Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double-blind study.

Authors:  L Schalén; P Christensen; I Eliasson; S Fex; C Kamme; C Schalén
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 Jan-Feb       Impact factor: 1.547

View more
  4 in total

1.  Labile type-specific antigen of Moraxella catarrhalis.

Authors:  S J Norkus; J W Vennes
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

2.  Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

Authors:  X X Gu; J Chen; S J Barenkamp; J B Robbins; C M Tsai; D J Lim; J Battey
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 3.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

4.  Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.

Authors:  I Jönsson; T Holme; A Krook; M Rahman; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.